Cirio Advokatbyrå AB houses a team which is noted for its ‘large and in-depth’ knowledge of the life sciences sector. The group handles a wide variety of mandates involving market access, rights issuances of shares, and trade mark mandates concerning parallel imports. Practice head Per Hedman utilises his vast regulatory knowledge to advise international pharma, medtech and biotech companies and investment entities. Praised for her specialism in personal data protection which makes her ‘unique within the Swedish market’, Hanna Tilus is known for advising on technology transfers, co-marketing issues, and R&D collaborations.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘This team blends strong, commercial legal work with a deep industry knowledge in life sciences. They are hard to match in this combination. The team is also very responsive on legal queries outside major engagements, meaning they act as a trusted and reliable adviser.’

  • ‘Per Hedman is our most trusted legal adviser in Sweden. He gives actionable, practical advice without unnecessary complexity. He blends this with deep life sciences expertise, making him a seamless lawyer to work with. He is responsive and always available in a crisis!’

  • ‘The Cirio team are solutions-oriented and deliver clear advice that is easy to implement in our internal routines and procedures.’

  • ‘Hanna Tilus has a deep understanding of the intersection between data protection and pharma, which makes her unique within the Swedish market. In addition to her excellent legal knowledge and experience, Hanna shows genuine understanding of our business, has a pragmatic approach, and is a joy to work with.’

  • ‘The team has vast experience in the life sciences space, and give great advice in different ways to structure a deal in most successful way.’

  • ‘Cirio is unique in its large and in-depth sector knowledge. Key strengths include having executed many types of transactions with clients, strategic intuition, and capacity.’

  • ‘My main contact is Per Hedman. Per stands out for his vast life sciences expertise, availability, and superior customer support. This has collectively built a genuine trust - regardless of the question I bring, I will receive superior support quickly.’

  • ‘Highly professional and knowledgeable, good service.’

Key clients

  • Takeda
  • 10x Genomics
  • Ipsen
  • Recipharm
  • Boule Diagnostics
  • Hadean Ventures
  • Karolinska Development
  • Intervacc
  • Scandinavian Biopharma
  • Sprint Bioscience
  • Abliva
  • Symcel
  • Annexin Pharmaceutcials
  • AlzeCure Pharma
  • Nordberg Medical
  • Lamera Medical
  • FrostPharma
  • Sprint Bioscience AB

Work highlights

  • Represented Takeda in a market access matter.
  • Advised Ipsen on its acquisition of Albireo Pharma Inc (including two Swedish subsidiaries).
  • Advised Boule Diagnostics AB on its rights issuance of shares through which the company raised approximately SEK150m.

Lawyers

Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.

Practice head

The lawyer(s) leading their teams.

Per Hedman

Other key lawyers

Odd Swarting, Hanna Tilus